Skip to main content
Premium Trial:

Request an Annual Quote

Decode Nets $18.4M on Sale, Lease-Back of Chicago Facility

NEW YORK (GenomeWeb News) — Decode Genetics has netted $18.4 million after selling and leasing back its Chicago-area medicinal chemistry facility, the company said today.
 
The company sold the Woodridge, Ill., facility for $25 million and leased the space back for a 17-year term, Decode said.
 
Decode said it plans to use the cash it made on the deal to fund its drug- and diagnostic-development programs.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.